Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gelderblom

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 11, 2020
Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and NorwayA J Breugom, E Bastiaannet, M G Guren, et al.
British Journal of Cancer|August 5, 2010
Myelosuppression by sunitinib is flt-3 genotype dependentN P van Erp, R H J Mathijssen, A A van der Veldt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumorsA J Wagner, H Kindler, H Gelderblom, et al.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Translational Oncology|June 28, 2017
High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor GrowthMarieke A de Graaff, Shruti Malu, Irma Guardiola, et al.
International Journal of Cancer|October 25, 2011
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancerM Heusinkveld, R Goedemans, R J P Briet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2018
Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registryP A Boonstra, N Steeghs, S Farag, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2022
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literatureJ M van Berge Henegouwen, H van der Wijngaart, L J Zeverijn, et al.
European Journal of Cancer Care|February 18, 2014
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO databaseD E Issa, H Gelderblom, P J Lugtenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2012
Adjuvant therapy in primary GIST: state-of-the-artP Reichardt, J-Y Blay, I Boukovinas, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 11, 2020
Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and NorwayA J Breugom, E Bastiaannet, M G Guren, et al.
British Journal of Cancer|August 5, 2010
Myelosuppression by sunitinib is flt-3 genotype dependentN P van Erp, R H J Mathijssen, A A van der Veldt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumorsA J Wagner, H Kindler, H Gelderblom, et al.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Translational Oncology|June 28, 2017
High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor GrowthMarieke A de Graaff, Shruti Malu, Irma Guardiola, et al.
International Journal of Cancer|October 25, 2011
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancerM Heusinkveld, R Goedemans, R J P Briet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2018
Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registryP A Boonstra, N Steeghs, S Farag, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2022
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literatureJ M van Berge Henegouwen, H van der Wijngaart, L J Zeverijn, et al.
European Journal of Cancer Care|February 18, 2014
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO databaseD E Issa, H Gelderblom, P J Lugtenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2012
Adjuvant therapy in primary GIST: state-of-the-artP Reichardt, J-Y Blay, I Boukovinas, et al.
Pageof 26